VantagePoint AI Stock of the Week – Eli Lilly ($LLY)
Wall Street is not debating whether Eli Lilly is a successful company. That question was settled years ago. The debate today is how much larger the company's opportunity can become. Analysts currently project targets ranging from $850 to $1,500, with a consensus target of $1,267. When a stock already trades above $1,100 and analysts still see additional upside, it tells you that investors remain focused on future earnings growth rather than current valuation.






